CREO Honored by Inc. Magazine as One of the Fastest-Growing Private Companies in U.S. Mid-Atlantic Region for Third Year Running

CREO Grew 61% in the Reported Two-Year Period

DURHAM, NC, February 27, 2024— CREO, the preferred consultancy to the world’s most promising companies that seek to improve human health, is thrilled to announce its third consecutive year of recognition on Inc. Magazine’s prestigious Regionals 2024: Mid-Atlantic list of the fastest growing companies.

The award-winning consultancy, which offers strategy, IT, M&A, cybersecurity, quality, and regulatory compliance services to growing life sciences and healthcare organizations, has been garnering strong recognition since its formation in 2015. But CREO is just getting started. A strategic recapitalization from Grant Avenue Capital, which CREO announced in September 2023, is enabling the organization to accelerate its aggressive expansion.

Susan Acker-Walsh, chief executive officer and co-founder of CREO Inc., expressed her gratitude for the recognition from Inc. “Being acknowledged as one of the fastest-growing private companies in the Mid-Atlantic region is a great honor for us at CREO. Our team’s enthusiasm and dedication to advancing the important work of our life sciences and healthcare clients is at the heart of our continued success. I’d like to express my sincere thanks to our entire team for their tireless efforts in accelerating the growth of our valued clients.”

“We’re truly grateful to Inc. Magazine for bestowing us with this exceptional ranking, and we extend our congratulations to all of the other companies with whom we share this honor,” said Mike Townley, president and co-founder of CREO Inc. “As we take a moment to celebrate the significant growth milestones achieved in the past three years, we also look excitedly to the future. We are proud to serve as the consultancy of choice for so many innovators in the life sciences and healthcare industries.”

The 2024 Inc. Regionals are ranked according to percentage revenue growth when comparing the years 2020 and 2023. To qualify, companies must have generated revenue by March 31, 2020, with at least $100,000 in revenue in 2020 and at least $2 million in revenue in 2023. They also must be privately held, for profit, based in the U.S., and independent (not a subsidiary or division of another company).

Complete results of the Inc. Regionals: Mid-Atlantic, including company profiles and an interactive database that can be sorted by industry, metro area, and other criteria, can be found at www.inc.com/regionals/mid-atlantic.

About CREO

CREO, Inc. is the preferred consultancy to the world’s most promising companies that seek to improve human health. CREO serves growing life sciences, healthcare, and private equity portfolio companies across the U.S. and international markets. The company’s expertise and knowledge in Strategy, M&A, Digital Transformation, Cybersecurity, and IT Quality & Regulatory Compliance help organizations improve today’s business performance and develop tomorrow’s clinical innovations. Founded in 2015, CREO is headquartered in North Carolina’s Research Triangle Park. Join us and together let’s make a meaningful difference. Visit CREO at www.creoinc.net.